XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (107,166) $ 38,098
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 12,028 12,519
Amortization of debt discount 0 7,611
Amortization of deferred debt issuance costs 3,404 2,946
Amortization 39,754 40,747
Stock-based compensation 15,972 12,003
Deferred income taxes 38,442 (1,311)
Loss on early extinguishment of debt 3,426 899
Loss on convertible notes conversion premium 103,125 0
Loss on convertible notes hedge transactions settlement 5,460 0
Increase (decrease) in cash flows from changes in assets and liabilities:    
Accounts receivable (16,092) 9,890
Inventories (52,126) (34,679)
Accounts payable 14,475 (6,223)
Accrued compensation and benefits (8,261) 5,030
Other assets (11,710) (15,915)
Other liabilities 4,232 6,370
Net cash provided by operating activities 44,963 77,985
Cash flows from investing activities:    
Purchases of property, plant and equipment (16,109) (11,678)
Payments related to business acquisition, net of cash acquired (227,102) 0
Net cash used in investing activities (243,211) (11,678)
Cash flows from financing activities:    
Payments on term loan (92,981) (63,673)
Proceeds from term loan 0 52,411
Payments on revolving line of credit (404,000) (272,753)
Proceeds from revolving line of credit 317,000 236,753
Payments to redeem convertible notes (275,000) 0
Proceeds from issuance of convertible notes 800,000 0
Payments related to debt issuance costs (21,830) (2,000)
Dividends paid on common stock (17,865) (17,418)
Purchases of convertible notes hedge transactions (187,600) 0
Proceeds from issuance of warrants 72,000 0
Proceeds from settlement of convertible notes hedge transactions 86,228 0
Payment for settlement of warrants (69,534) 0
Other, net 7,067 5,921
Net cash provided by (used in) financing activities 213,485 (60,759)
Effect of exchange rate changes on cash and cash equivalents (2,730) (1,393)
Net increase in cash and cash equivalents 12,507 4,155
Cash and cash equivalents at beginning of period 20,847 27,356
Cash and cash equivalents at end of period 33,354 31,511
Non-cash investing and financing activities:    
Contingent consideration 183,914 0
Dividends payable $ 6,095 $ 5,837